Aclarion (ACON) Expected to Announce Earnings on Wednesday

Aclarion (NASDAQ:ACON) is expected to be releasing its Q2 2025 earnings data before the market opens on Wednesday, August 13th. Analysts expect Aclarion to post earnings of ($2.26) per share for the quarter.

Aclarion (NASDAQ:ACON) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($9.32) EPS for the quarter, topping analysts’ consensus estimates of ($1,447.20) by $1,437.88. The business had revenue of $0.02 million during the quarter, compared to the consensus estimate of $0.02 million. Aclarion had a negative return on equity of 126.89% and a negative net margin of 12,227.10%. On average, analysts expect Aclarion to post $-263 EPS for the current fiscal year and $-217 EPS for the next fiscal year.

Aclarion Trading Up 0.9%

NASDAQ:ACON opened at $7.24 on Tuesday. Aclarion has a one year low of $6.20 and a one year high of $3,499.51. The stock has a 50-day simple moving average of $7.29 and a 200 day simple moving average of $32.75.

Analyst Ratings Changes

A number of equities analysts have issued reports on ACON shares. Wall Street Zen raised shares of Aclarion from a “sell” rating to a “hold” rating in a report on Saturday, May 31st. Ascendiant Capital Markets raised shares of Aclarion to a “moderate buy” rating in a report on Friday, May 30th.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.